Filed: 2026-04-20 AccNo: 0001193125-26-164201 Size: 540 KB
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
424B5 - NEKTAR THERAPEUTICS
Filed:
2026-04-23
AccNo:
0001193125-26-171717
Size:
643 KB
发布时间04/23 10:02 UTC
首次发现04/23 10:05 UTC
热度102.7
重要度38
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 617 字符
Form 424B5 - Prospectus [Rule 424(b)(5)]: SEC Accession No. 0001193125-26-171717
Filing Date: 2026-04-23
Accepted: 2026-04-23 06:02:31
Documents: 13
NEKTAR THERAPEUTICS (Filer) CIK : 0000906709 (see all company filings) EIN. : 943134940 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 424B5 | Act: 33 | File No.: 333-291466 | Film No.: 26885369 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 424B5 | d138057d424b5.htm | 424B5
2 | EX-FILING FEES | d138057dexfilingfees.htm iXBRL | EX-FILING FEES
3 | GRAPHIC | g138057g02a02.jpg | GRAPHIC
4 | GRAPHIC | g138057g32t43.jpg | GRAPHIC
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇